Preclinic Medtech's Model Assists in Basic Research on Cerebrovascular Diseases at PLA General Hospital (301 Hospital)

The mechanical thrombectomy has become an important method for treating acute ischemic stroke with large blood vessel occlusion. The current focus of mechanical thrombectomy is to optimize treatment methods, improve recanalization rates, and reduce complications. In vitro models have become commonly used and convenient methods in the research of mechanical thrombectomy, which are of great significance for the evaluation of new thrombectomy devices.

Based on the research needs of the Biomedical Engineering Research Center of the Chinese PLA General Hospital (301 Hospital), the professional surgical simulator manufacturer Preclinic Medtech (Shanghai) Co., Ltd. continuously improves the in vitro experimental model according to its characteristics and applications.

Assisting Dr. Liu Ronghui's team from the Biomedical Engineering Research Center of the Chinese PLA General Hospital (301 Hospital) in the evaluation of mechanical thrombectomy devices in in vitro experiments.

Topic You May Interested In:

Thoracic Anesthesia Bronchoscopy Simulator

Usability Testing in China